Skip to main content
Top
Published in: Rheumatology International 11/2008

01-09-2008 | Original Article

Are individuals with severe haemophilia A prone to reduced bone density?

Authors: Hassan Mansouritorghabeh, Zahra Rezaieyazdi, Zahra Badiei

Published in: Rheumatology International | Issue 11/2008

Login to get access

Abstract

Individuals with severe haemophilia A may be at risk for reduced bone mineral density because of reduced weight-bearing exercise and hepatitis C infection. For confirming the reduced bone density, in the current cross-sectional study, we tried to address bone mineral density in individuals with severe haemophilia A and surveyed the relation of reduced bone density with hepatitis C viruses. To fulfil these aims, bone density and biochemical indexes in 18 individuals with severe haemophilia A and also in 18 individuals matched for age, sex, weight and height, as the control group, were examined. The obtained results showed that individuals with severe haemophilia A had reduced bone density (1.136 ± 0.118, 0.801 ± 0.238) in lumbar and femur regions, respectively, in comparison with the age- and sex-matched group (1.299 ± 0.237, 1.458 ± 0.505). The major complications of coagulation disorders are various types of excessive bleeding. The current study describes an association between severe haemophilia A and osteopenia, specifically at both the femur and the lumbar spine.
Literature
1.
go back to reference Barnes C, Wong P, Egan B, Speller T, Cameron F, Jones G, Ekert H, Monagle P (2004) Reduced bone density among children with severe haemophilia. Pediatrics 114(2):117–181CrossRef Barnes C, Wong P, Egan B, Speller T, Cameron F, Jones G, Ekert H, Monagle P (2004) Reduced bone density among children with severe haemophilia. Pediatrics 114(2):117–181CrossRef
2.
go back to reference Byers RJ, Hoyland JA, Braidman IP (2001) Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem. J Endocrinol 168:353–362PubMedCrossRef Byers RJ, Hoyland JA, Braidman IP (2001) Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem. J Endocrinol 168:353–362PubMedCrossRef
3.
go back to reference Eisman J, Kelly P, Morrison N (1993) Peak bone mass and osteoporosis prevention. Oseteoporosis Int 3:56–60CrossRef Eisman J, Kelly P, Morrison N (1993) Peak bone mass and osteoporosis prevention. Oseteoporosis Int 3:56–60CrossRef
4.
go back to reference Mora S, Gilsanz V (2003) Establishment of peak bone mass. Endocrinol Metab Clin North Am 32:39–63PubMedCrossRef Mora S, Gilsanz V (2003) Establishment of peak bone mass. Endocrinol Metab Clin North Am 32:39–63PubMedCrossRef
5.
go back to reference Gallacher SJ, Deighan C, Wallace AM, Cowan RA, Fraser WD, Fenner JA, Lowe GD, Boyle IT (1994) Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study. Q J Med 87:181–186PubMed Gallacher SJ, Deighan C, Wallace AM, Cowan RA, Fraser WD, Fenner JA, Lowe GD, Boyle IT (1994) Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study. Q J Med 87:181–186PubMed
6.
go back to reference Mansouritorghabeh H, Pourfathollah AA, Mahmoodian Shooshtari M, Rezaieyazdi Z (2004) Pattern of factor VIII inhibitor in haemophilia A in Korassan province. Hakim Res J 7(3):1–5 Mansouritorghabeh H, Pourfathollah AA, Mahmoodian Shooshtari M, Rezaieyazdi Z (2004) Pattern of factor VIII inhibitor in haemophilia A in Korassan province. Hakim Res J 7(3):1–5
7.
go back to reference Inzerillo AM, Zaidi M (2002) Osteoporosis: trends and intervention. Mount Sinai J Med 69(4):220–231 Inzerillo AM, Zaidi M (2002) Osteoporosis: trends and intervention. Mount Sinai J Med 69(4):220–231
8.
go back to reference Griffith GC, Nichols G, Asher JD, Flanagan B (1965) Heparin osteoporosis. JAMA 193:91–94PubMed Griffith GC, Nichols G, Asher JD, Flanagan B (1965) Heparin osteoporosis. JAMA 193:91–94PubMed
9.
go back to reference Riggs BL, Melton LJ (1986) Involutional osteoporosis. N Engl J Med 314(26):1678–1685 Riggs BL, Melton LJ (1986) Involutional osteoporosis. N Engl J Med 314(26):1678–1685
10.
go back to reference Conde FA, Aronson WJ (2003) Risk factors for male osteoporosis. Urol Oncol 21:380–383PubMed Conde FA, Aronson WJ (2003) Risk factors for male osteoporosis. Urol Oncol 21:380–383PubMed
Metadata
Title
Are individuals with severe haemophilia A prone to reduced bone density?
Authors
Hassan Mansouritorghabeh
Zahra Rezaieyazdi
Zahra Badiei
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0591-y

Other articles of this Issue 11/2008

Rheumatology International 11/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.